Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Levothyroxine sodium - Generic Drug Details

« Back to Dashboard
Levothyroxine sodium is the generic ingredient in nine branded drugs marketed by King Pharms R And D, Abbvie, Stevens J, Lloyd, Inst Biochimique, Institut Biochimique, Fresenius Kabi Usa, Lehigh Valley, Alara Pharm, Merck Kgaa, Fera Pharms Llc, Par Sterile Products, and Mylan, and is included in fourteen NDAs. There are nine patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

This ingredient has fifty-two patent family members in sixteen countries.

There are nine drug master file entries for levothyroxine sodium. Forty-three suppliers are listed for this compound.

Summary for Generic Name: levothyroxine sodium

Drug Master File Entries: see list9
Suppliers / Packaging: see list43
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
Drug Prices:see low prices

Pharmacology for Ingredient: levothyroxine sodium

Drug Classl-Thyroxine

Clinical Trials for: levothyroxine sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms R And D
levothyroxine sodium
TABLET;ORAL021301-011May 25, 2001RXYes7,101,569Oct 2, 2023
Institut Biochimique
levothyroxine sodium
CAPSULE;ORAL021924-005Oct 13, 2006RXNo7,723,390Mar 14, 2024Y
Alara Pharm
levothyroxine sodium
TABLET;ORAL021342-012Dec 8, 2003RXNo
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: levothyroxine sodium

Country Document Number Estimated Expiration
Denmark1433478► subscribe
Canada2438907► subscribe
World Intellectual Property Organization (WIPO)02067854► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.